Strategic Charitable Giving for Dementia Care: Types and Tax Benefits
Supporting dementia care through charitable contributions not only aids vital research and services but also offers a meaningful way to honor affected loved ones.
Dementia Friendly Fulton – Milestone Proclamation
On February 7th, members of the Dementia Friendly Fulton Coalition stood together declaring February 7th, 2024, Dementia Awareness Day.
Ways Memory Care Assisted Living Can Help Those Dealing with Dementia
There are numerous ways that a memory care assisted living community can make a difference for somebody with dementia. Here are some considerations.
Start the New Year Off with the Best Memory Care for One With Dementia
There are many different forms of memory care, but the one that may very well be the best is assisted living. Why would assisted living be the best option?
Essential Legal Planning for Dementia
This guide aims to outline the key legal steps for families navigating dementia care, providing clarity and peace of mind during a challenging time.
Things to Consider About Assisted Living for a Parent with Alzheimer’s
When you reach the crossroads where assisted living for a parent with Alzheimer’s is an option, there are several things to consider. Let’s take a look at three of them.
Understanding VA’s Aid and Attendance Benefits for Veterans with Dementia
For many families caring for veterans, the Veterans Affairs (VA) Aid and Attendance (A&A) benefit can be an invaluable resource.
For a Senior with Alzheimer’s, Memory Care Becomes Essential
One of the most common things family members do when an aging loved one is diagnosed with Alzheimer’s is rally around but do not turn your back on other types of memory care services to support them.
Dementia – 5 Top Factors that Influence Hearing Aid Use
Here are some factors that may affect a person’s successful use of hearing aids and some interventions we can use to encourage proper and more frequent wear.
FDA Approves Drug to Treat Agitation in Alzheimer’s Dementia
On Thursday, May 11th, the Food and Drug Administration approved, for the first time, a drug to treat agitation symptoms in Alzheimer’s disease.